Is It Time to Reevaluate Radiotherapy Omission in Older Patients With Favorable Early-Stage Breast Cancer?

Cost-effectiveness analysis of endocrine therapy alone versus partial-breast irradiation alone versus combined treatment for low-risk hormone-positive early-stage breast cancer in women aged 70 years or older

(2020) Matthew C. Ward et al.   BREAST CANCER RESEARCH AND TREATMENT

Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105

(2020) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

(2020) Adrian Murray Brunt et al.   LANCET

Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial

(2020) Icro Meattini et al.   JOURNAL OF CLINICAL ONCOLOGY

Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer

(2015) Wei He et al.   JOURNAL OF CLINICAL ONCOLOGY

Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy

(2014) Chirag Shah et al.   RADIOTHERAPY AND ONCOLOGY

Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343

(2013) Kevin S. Hughes et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials

(2011)   LANCET